- Home
- / Algorae Pharmaceuticals
Algorae Pharmaceuticals
Stock Price
$0
2023-09-29
Market Capitalization
$22.9 M
2023-09-29
Algorae Pharmaceuticals Summary
Company Summary
- Overview
- Algorae Pharmaceuticals (formerly known as Living Cell Technologies Limited (LCT)) is a biotechnology company discovering, developing, and commercializing treatments that use the regenerative healing properties of naturally occurring cells. It focuses on developing cell therapies to treat neurological disorders.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Auckland, NZ | view all locations
- Website
- https://algoraepharma.com/
- Cybersecurity rating
Table of Contents
Key People
Robert Willcocks, Independent Director
Andrew Kelly, Non-Executive Director
Daya Uka, Chief Financial Officer
LocationsView all
2 locations detected
Auckland, Auckland HQ
New Zealand
107/23 Edwin Street, Mount Eden
Melbourne, VIC
Australia
level 7/330 Collins St
Algorae Pharmaceuticals Financials
Summary Financials
- Net income (H1, 2026)
- ($864.0K)
- Cash (H1, 2026)
- $1.1M
- EBIT (H1, 2026)
- ($1.2M)